Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Cash flows from operating activities:    
Net loss $ (2,319,867) $ (1,316,752)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest expense - debt discount 4,795
Non-cash consulting expense from issuance of common stock 85,422
Stock-based compensation to employees and consultants 739,622 506,011
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (216,169) 346,529
Accounts payable and accrued expenses 568,955 173,694
Net cash used in operating activities (1,222,664) (205,096)
Cash flows from investing activities:    
Proceeds from repayments of notes receivable - related party 100,915
Net cash provided by investing activities 100,915
Cash flows from financing activities:    
Proceeds from the issuance of common stock and warrants - related party, net 2,000,000
Proceeds from stock option exercise 100
Proceeds from notes payable 62,110
Proceeds from convertible note payable, related party 14,900
Proceeds from initial public offering, net of underwriters' discounts and        commissions and issuance costs 12,911,456
          Net cash provided by financing activities 14,911,556 77,010
Net increase (decrease) in cash 13,688,892 (27,171)
Cash at beginning of period 1,929,270 90,285
Cash at end of period 15,618,162 63,114
Non-cash financing activities:    
Fair value of warrants issued in connection with IPO 461,877
Fair value of warrants issued in connection with March 2021 securities purchase agreement, related party $ 4,799,742